Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
CorFlow Therapeutics to raise €44M in a Series B financing round with Wellington Partners, Unorthodox Ventures, Panakes Partners, Monte Carlo Capital

CorFlow Therapeutics to raise €44M in a Series B financing round with Wellington Partners, Unorthodox Ventures, Panakes Partners, Monte Carlo Capital

Biotech Health services Pharma

Switzerland

Germany

United States

France

Italy

United Kingdom

Singapore

Investments

03 September 2024

Share:

CorFlow Therapeutics (company)

Switzerland

Biotech Health services Pharma

Total investments received (USD): 57.01m

Round value (USD): 48.4m

Round investors: 415 Capital Broadview Ventures Merieux Equity Partners Panakès Partners Wellington Partners Unorthodox Ventures Monte Carlo Capital M&L Healthcare Laerdal Million Lives Fund KOFA Healthcare Investments

Company: CorFlow Therapeutics

Industry: Biotech Health services Pharma

Related deals

Noema Pharma raised €36m in Series B extension funding led by EQT, joined by Forbion, Jeito Capital, Sofinnova, Gilde Healthcare, Polaris Partners, Invus

Biotech Health services

Switzerland

Sweden

Netherlands

United States

France

Investments 02 December 2024

Memo Therapeutics raised CHF 20 million in Series C extension funding from investors including Ysios Capital and Kurma Partners.

Biotech Health services Manufacturing

Switzerland

France

Spain

Investments 01 May 2024

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top